Lifestream cholesterol test
This article was originally published in The Tan Sheet
Lifestream Technologies receives FDA 510k clearance to market consumer cholesterol test incorporating Health Risk Assessment technology, enabling users to track cholesterol levels as well as personal risk of heart attack and obesity. Users can obtain a Health Risk Assessment profile after taking a three-minute cholesterol test and entering additional risk factors, including diabetic status, systolic and diastolic blood pressure and HDL-C break-out from a recent lipid profile. The test will be available to consumers through the firm's 1website in late June and move to other distribution channels later this year. McNeil recently announced a licensing agreement with International Medical Innovations to develop and market the PREVU(x) consumer cholesterol test (2"The Tan Sheet" June 7, 2004, p. 10)...
You may also be interested in...
McNeil Consumer Health is seeking to leverage the potential Rx-to-OTC switch of J&J/Merck's Mevacor (lovastatin) with an agreement to license International Medical Innovations' predictive tests for coronary artery disease (CAD)
CEO Werner Baumann admits he was skeptical at first as to whether the German group had the necessary know-how to manufacture vaccines but the firm's expertise in the development of biotech products has strengthened his belief Bayer can deliver.
As part of its big data initiative, the European Medicines Agency is supporting projects that will help identify appropriate real-world data sources for regulatory decision making.